Business Wire
BusinessiShares IAI puts a spotlight on U.S. securities trading revenue, but ETF mechanics still matter for investorsThe Apex TimesBusinessYahoo Finance column pitches a single “10-year” dividend bet, weighing Verizon’s higher yield against Chevron’s lower payoutThe Apex TimesBusinessBlackRock and iShares Infrastructure ETFs: what investors are weighing in IFRA-focused coverageThe Apex TimesBusinessHumana forms joint venture with BlackRock-managed funds to run CenterWell senior primary care clinicsThe Apex TimesBusinessJohnson & Johnson declares $1.34 quarterly dividend for fourth quarter of 2026The Apex TimesBusinessJPMorgan and major peers head into Q3 earnings as investors weigh Treasury yields and loan riskThe Apex TimesBusinessGoldman and JPMorgan shares climb before major bank earnings; investors show signs of rotating toward financeThe Apex TimesBusinessUnitedHealth’s Earnings Top Wall Street Estimates as Medical-Cost Pressure Shows Signs of EasingThe Apex TimesBusinessUnitedHealth raises full-year 2026 guidance after reporting third-quarter resultsThe Apex TimesBusinessHolm Security rolls out Microsoft 365 security assessment as it expands vulnerability management platformThe Apex TimesBusinessUnitedHealth reports third-quarter profit, shares focus turns to what drove results and guidanceThe Apex TimesBusinessBroadcom CEO Hock Tan tells investors they do not understand what they own, invoking a Warren Buffett lessonThe Apex TimesBusinessiShares IAI puts a spotlight on U.S. securities trading revenue, but ETF mechanics still matter for investorsThe Apex TimesBusinessYahoo Finance column pitches a single “10-year” dividend bet, weighing Verizon’s higher yield against Chevron’s lower payoutThe Apex TimesBusinessBlackRock and iShares Infrastructure ETFs: what investors are weighing in IFRA-focused coverageThe Apex TimesBusinessHumana forms joint venture with BlackRock-managed funds to run CenterWell senior primary care clinicsThe Apex TimesBusinessJohnson & Johnson declares $1.34 quarterly dividend for fourth quarter of 2026The Apex TimesBusinessJPMorgan and major peers head into Q3 earnings as investors weigh Treasury yields and loan riskThe Apex TimesBusinessGoldman and JPMorgan shares climb before major bank earnings; investors show signs of rotating toward financeThe Apex TimesBusinessUnitedHealth’s Earnings Top Wall Street Estimates as Medical-Cost Pressure Shows Signs of EasingThe Apex TimesBusinessUnitedHealth raises full-year 2026 guidance after reporting third-quarter resultsThe Apex TimesBusinessHolm Security rolls out Microsoft 365 security assessment as it expands vulnerability management platformThe Apex TimesBusinessUnitedHealth reports third-quarter profit, shares focus turns to what drove results and guidanceThe Apex TimesBusinessBroadcom CEO Hock Tan tells investors they do not understand what they own, invoking a Warren Buffett lessonThe Apex TimesBusinessiShares IAI puts a spotlight on U.S. securities trading revenue, but ETF mechanics still matter for investorsThe Apex TimesBusinessYahoo Finance column pitches a single “10-year” dividend bet, weighing Verizon’s higher yield against Chevron’s lower payoutThe Apex TimesBusinessBlackRock and iShares Infrastructure ETFs: what investors are weighing in IFRA-focused coverageThe Apex TimesBusinessHumana forms joint venture with BlackRock-managed funds to run CenterWell senior primary care clinicsThe Apex TimesBusinessJohnson & Johnson declares $1.34 quarterly dividend for fourth quarter of 2026The Apex TimesBusinessJPMorgan and major peers head into Q3 earnings as investors weigh Treasury yields and loan riskThe Apex TimesBusinessGoldman and JPMorgan shares climb before major bank earnings; investors show signs of rotating toward financeThe Apex TimesBusinessUnitedHealth’s Earnings Top Wall Street Estimates as Medical-Cost Pressure Shows Signs of EasingThe Apex TimesBusinessUnitedHealth raises full-year 2026 guidance after reporting third-quarter resultsThe Apex TimesBusinessHolm Security rolls out Microsoft 365 security assessment as it expands vulnerability management platformThe Apex TimesBusinessUnitedHealth reports third-quarter profit, shares focus turns to what drove results and guidanceThe Apex TimesBusinessBroadcom CEO Hock Tan tells investors they do not understand what they own, invoking a Warren Buffett lessonThe Apex TimesBusinessiShares IAI puts a spotlight on U.S. securities trading revenue, but ETF mechanics still matter for investorsThe Apex TimesBusinessYahoo Finance column pitches a single “10-year” dividend bet, weighing Verizon’s higher yield against Chevron’s lower payoutThe Apex TimesBusinessBlackRock and iShares Infrastructure ETFs: what investors are weighing in IFRA-focused coverageThe Apex TimesBusinessHumana forms joint venture with BlackRock-managed funds to run CenterWell senior primary care clinicsThe Apex TimesBusinessJohnson & Johnson declares $1.34 quarterly dividend for fourth quarter of 2026The Apex TimesBusinessJPMorgan and major peers head into Q3 earnings as investors weigh Treasury yields and loan riskThe Apex TimesBusinessGoldman and JPMorgan shares climb before major bank earnings; investors show signs of rotating toward financeThe Apex TimesBusinessUnitedHealth’s Earnings Top Wall Street Estimates as Medical-Cost Pressure Shows Signs of EasingThe Apex TimesBusinessUnitedHealth raises full-year 2026 guidance after reporting third-quarter resultsThe Apex TimesBusinessHolm Security rolls out Microsoft 365 security assessment as it expands vulnerability management platformThe Apex TimesBusinessUnitedHealth reports third-quarter profit, shares focus turns to what drove results and guidanceThe Apex TimesBusinessBroadcom CEO Hock Tan tells investors they do not understand what they own, invoking a Warren Buffett lessonThe Apex Times
Back to front
ExxonMobil among reported bidders for Shell’s U.S. chemicals business, market talks drive valuation focus
The Apex Times

THE APEX TIMES

Business/The Apex Times/Sep 2, 4:32 AM EDT

ExxonMobil among reported bidders for Shell’s U.S. chemicals business, market talks drive valuation focus

A report said Exxon Mobil is among several bidders for Shell’s portfolio of four U.S. chemicals plants, a deal that could be valued around $8 billion, reviving interest in how efficiently large energy groups can redeploy capital into chemicals.

Exxon Mobil (XOM) has returned to investor focus after a report that the company is among several potential bidders for Shell’s U.S. chemicals business. The package, described as consisting of four plants, is said to be of interest because of its scale and the potential value implied by the bidding process, according to the market talk.

The Yahoo Finance report framed the situation around the possibility that Shell’s U.S. chemicals assets could be sold for close to $8 billion. It also described ExxonMobil as one of the bidders, putting a major oil and gas producer into a sales process that is typically dominated by chemicals specialists and integrated energy-to-chemicals players.

Chemicals businesses are often valued differently from upstream oil and gas. While crude production is tied to commodity cycles, chemicals demand is influenced by industrial activity, consumer spending, and construction activity, and pricing can be shaped by feedstock costs and global supply balances. That means a chemicals portfolio can represent a different risk profile and a different earnings engine than traditional refining or exploration.

ExxonMobil’s involvement, if confirmed, would underline the company’s long-standing interest in integrating upstream advantages with downstream petrochemical production. However, the report did not provide deal structure details, timelines, or specific operational performance metrics for the four-plant portfolio, and it did not state whether ExxonMobil would participate as a buyer alone or as part of a consortium.

For Shell, the reported sale of the U.S. chemicals business would fit into a broader pattern in which major energy firms evaluate which downstream and chemicals assets best match their capital allocation and portfolio strategy. Asset sales of this type can also be used to reduce complexity or to generate cash for investment priorities in other parts of the business, though the market talk did not offer specifics on Shell’s stated objectives.

The reported $8 billion magnitude matters because it suggests the assets are large enough to attract heavyweight industrial buyers and because the price level would be watched closely by investors for indicates about margins and long-term demand. If bidders emerge and terms become clearer, market participants would likely concentrate on which chemical product lines are included, the extent of contracts with customers, and the degree to which the plants are linked to particular feedstocks.

Still, much remains unconfirmed based on the available reporting. The market post did not disclose whether ExxonMobil has submitted a binding offer, the presence of due diligence, financing assumptions, or what valuation methodology different bidders are using. Until Shell or ExxonMobil provides additional information, observers should treat the discussion as preliminary and focused on the existence of interest rather than a final sale commitment.

Why It Matters

  • A potential move into a large chemicals portfolio would test how investors price ExxonMobil’s optionality beyond oil and gas cycles.
  • The size of the reported valuation benchmark could influence expectations for chemicals margins and asset pricing in the U.S. market.
  • If the process advances, details on plant product mix, feedstock linkages, and contract structures would likely become key drivers for investor sentiment.

Sources

Key Facts

  • Yahoo Finance reported that Exxon Mobil is among several bidders for Shell’s U.S. chemicals business.
  • The assets described in the report are a portfolio of four U.S. plants.
  • The report said the portfolio could be valued near $8 billion.
  • The reporting did not outline specific deal terms, timelines, or whether offers are binding.

Energy & Industrials Related